CD274 and intrahepatic cholangiocarcinoma: Therefore, we designed a Phase II study to evaluate the efficacy and safety of HAIC with GC followed by capecitabine combined with PDL1 inhibitors (HgcCP) as the postoperative adjuvant treatment for high-risk ICC after curative surgery.